Images List Premium Download Classic

Infectious Disease

Infectious Disease-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Methods for the treatment of disease using immunoglobulins having fc regions with altered affinities for ...
Macrogenics, Inc.
January 11, 2018 - N°20180009902

The present invention relates to methods of treating or preventing cancer and other diseases using molecules, particularly polypeptides, more particularly immunoglobulins (e. G., antibodies), comprising a variant fc region, wherein said variant fc region comprises at least one amino acid modification relative to a wild-type fc region, which variant fc region binds an fcγr that activates a ...
Modulation of antigen immunogenicity by deleting epitopes recognized by nkt cells
Imnate Sarl
January 11, 2018 - N°20180009843

The invention describes a method and compounds for the prevention of immune responses towards allofactors, towards viral vectors used for gene therapy and gene vaccination, towards proteins to which subjects are naturally exposed, towards genetically-modified organisms and towards undesirable effects related to vaccine administration for allergic or infectious diseases.
Enterococcus faecalis and/or enterococcus faecium antigen
Universitätsklinikum Freiburg
January 11, 2018 - N°20180009834

The present invention generally relates to the field of detecting and preventing infectious diseases caused by enterococcus faecalis and/or enterococcus faecium. More specifically, the invention relates to an enterococcus faecalis and/or enterococcus faecium antigen which comprises at least one unit having the following general formula:
Infectious Disease Patent Pack
Download 152+ patent application PDFs
Infectious Disease Patent Applications
Download 152+ Infectious Disease-related PDFs
For professional research & prior art discovery
inventor
  • 152+ full patent PDF documents of Infectious Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compounds, compositions and associated methods comprising 3-aryl quinolines
The United States Government As Represented By The Department Of Veterans Affairs
January 11, 2018 - N°20180009760

Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed.
Lactic-acid-bacteria-containing composition, oral pharmaceutical composition for treating hpv infection and/or hpv-associated tumors, and mucosal ...
Japan Health Sciences Foundation
January 11, 2018 - N°20180008663

A lactic acid bacterium-containing composition including a lactic acid bacterium having a human papillomavirus (hpv) e7 protein-derived polypeptide on a surface thereof, wherein the hpv e7 protein-derived polypeptide is included in an amount of 0. 03 μg to 1. 0 μg per 1×108 lactic acid bacteria; a therapeutic oral pharmaceutical composition for at least one of an hpv infectious disease ...
Use of prostacyclin antagonists for treating ocular surface nociception
Jenivision Inc.
January 11, 2018 - N°20180008578

The present invention relates generally to the use of compositions and methods for treating nociceptive events that occur on the ocular surface in association with dryness, injury, environmental pollutants, and infectious and non-infectious diseases. Specifically, the present invention is directed to the use of certain compounds for treating for treating ocular pain or ocular discomfort.
Infectious Disease Patent Pack
Download 152+ patent application PDFs
Infectious Disease Patent Applications
Download 152+ Infectious Disease-related PDFs
For professional research & prior art discovery
inventor
  • 152+ full patent PDF documents of Infectious Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Targeted conjugates and particles and formulations thereof
Tarveda Therapeutics, Inc.
January 04, 2018 - N°20180000959

Nanoparticles and microparticles, and pharmaceutical formulations thereof, containing conjugates of an active agent such as a therapeutic, prophylactic, or diagnostic agent attached to a targeting moiety, such as a somatostatin receptor binding moiety, via a linker have been designed. Such nanoparticles and microparticles can provide improved temporospatial delivery of the active agent and/or improved biodistribution. Methods of making the ...
Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
Riken
January 04, 2018 - N°20180000921

Compositions consisting of bioactive molecules derived from the microbiota of a mammal are provided herein. When administered orally with a colonic delivery system, the compositions are useful for the prophylaxis and treatment of diseases, in particular inflammatory, autoimmune and infectious diseases. The compositions comprise combinations of small molecules and bacterial antigens formulated in colonic delivery systems. Use of the compositions ...
Stable formulations for the oral administration of amphotericin b and related methods
Ico Therapeutics Inc.
January 04, 2018 - N°20180000854

The present invention provides oral ampb and/or protease inhibitor formulations and their use to treat infectious disease, including hiv.
Methods for immunomodulation of cancer and infectious disease therapy
The Regents Of The University Of California
January 04, 2018 - N°20180000747

The present invention provides methods for modulating the immune response of a subject to a therapeutic agent, the method comprising administering an effective amount of a triphenylethylene (trip) compound with an effective amount of the therapeutic agent. In particular embodiments, the trip compound enhances the immune response of the subject to the therapeutic agent. In some embodiments, the trip compound ...
Method for identifying pathogens of bacterial infectious diseases by using bacteria-derived nanovesicles
Md Healthcare Inc.
December 28, 2017 - N°20170369930

The present invention relates to a method for predicting causative factors (bacteria) of serious bacterial infectious diseases in a clinical sample containing bacteria-derived nano-sized extracellular vesicles, that is, nanovesicles, through the analysis of the genes contained in the nanovesicles. According to the present invention, information on bacteria of serious bacterial infection can be provided, a causative factor of the bacterial ...
Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions
Bristol-myers Squibb Company
December 28, 2017 - N°20170369530

The present disclosure provides novel macrocyclic peptides which inhibit the pd-1/pd-l1 and pd-l1/cd80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
Duke University
December 28, 2017 - N°20170368050

Disclosed herein are methods of diagnosing and treating infectious disease characterized by a pathology that involves hemorrhaging or pathological vascular leakage.
Infectious Disease Patent Pack
Download 152+ patent application PDFs
Infectious Disease Patent Applications
Download 152+ Infectious Disease-related PDFs
For professional research & prior art discovery
inventor
  • 152+ full patent PDF documents of Infectious Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method for preparing a vaccine antigen, resulting vaccine antigen and uses
Inserm
December 21, 2017 - N°20170362578

The present invention relates to a method for preparing a vaccine antigen, which includes a step of fragmenting a biological membrane associated with said vaccine antigen by treating said biological membrane with at least one calixarene of formula (ii): wherein: x is a —(ch2)-co2y group and y is an alkaline metal or one of the pharmaceutically acceptable ...
Cd47 targeted therapies for the treatment of infectious disease
The Regents Of The University Of California
December 21, 2017 - N°20170362332

Methods are provided for treating a subject with for an intracellular pathogen infection, by administering an agent that reduces the binding of cd47 on a infected cell to sirpα on a host phagocytic cell, in an effective dose for increasing the phagocytosis of infected cells.
Peptidomimetic macrocycles and uses thereof
Aileron Therapeutics, Inc.
December 21, 2017 - N°20170360881

Provided herein are peptidomimetic macrocycles and methods of using such macrocycles for the treatment of disorders, for example, for treatment of infectious diseases.
Pd-l1 specific monoclonal antibodies for disease treatment and diagnosis
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
December 14, 2017 - N°20170355770

The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-pd-l1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous ...
Bandages for supplying ozone therapy
Umm-al-qura University
November 30, 2017 - N°20170340870

The present disclosure relates to a bandage wherein the bandage comprise of a first layer of protective covering, wherein the first layer is removable; a second layer of covering, wherein the second layer of covering is made of a cloth material; a third layer of covering, wherein the third layer is the top most layer of the bandage and together ...
Methods for making novel antigen binding domains
Chimera Bioengineering, Inc.
November 23, 2017 - N°20170336393

The present invention relates generally to the field of making novel antigen binding domains against infectious diseases. The present invention also relates to novel cars that utilize the novel antigen binding domains as an extracellular element. The present invention also relates to use of the novel antigen binding domains as therapeutic agents.
Methods and compositions for the activation of gamma-delta t-cells
American Gene Technologies International Inc.
November 23, 2017 - N°20170335344

The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta t-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
Nitroimidazole compound, preparation method therefor and use thereof in drug manufacturing
Shanghai Sun-sail Pharmaceutical Science & Technology Co., Ltd.
November 23, 2017 - N°20170334927

A nitroimidazole compound represented by general formula (i) or an optical isomer thereof or a pharmaceutically acceptable salt thereof, and a preparation method therefore, and use thereof in manufacturing drugs for the treating infectious diseases caused by mycobacterium tuberculosis. Specific groups in general formula (i) are as defined in the specification.
Loading